Mllt6 - myeloid/lymphoid or mixed-lineage leukemia; translocated to, 6

Predicted to enable histone binding activity and nucleosome binding activity. Acts upstream of or within several processes, including negative regulation of histone H3-K79 methylation; renal potassium excretion; and renal sodium excretion. Predicted to be active in nucleus. Is expressed in several structures, including early conceptus; forelimb bud; genitourinary system; nervous system; and sensory organ. Orthologous to human MLLT6 (MLLT6, PHD finger containing). [provided by Alliance of Genome Resources, Apr 2022]